-- The NEW Official Alizyme Thread! --

Judge Jury (Post 20256) I think there are several things to note about Cetilistat in comparison with Accomplia and Xenical, as follows:

1) The market for obesity is large and growing, so however one looks at it, potential sales of Cetilistat should be large. Infact, Datamonitor have suggested it could be the market leader in terms of sales.

2) Cetilistat addresses conditions of extreme obesity, plus obesity + type II diabetes, which require drug treatment (and possibly adolescent obesity).

"Drug treatment is being recommended for individuals with a Body Mass Index of
over 30" (Source: Footnotes to AZM's press releases on Cetilistat).

3) Cetilistat has a better side effects profile and is cheaper to produce than Xenical, and is safer than appetite suppressents such as Accomplia, so it has competitive advantages.